FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040066655> ?p ?o ?g. }

• W2040066655 endingPage "216" @default.
• W2040066655 startingPage "204" @default.
• W2040066655 abstract "Controversy exists over whether pretransplantation consolidation chemotherapy affects the outcome of subsequent autotransplantation for acute myelogenous leukemia (AML). The current study was undertaken to determine the association between previous consolidation and outcome of autotransplantation for AML in first remission. Posttransplantation outcomes of 146 patients receiving no consolidation were compared with those of 244 patients receiving standard-dose (<1 gm/m(2)) and 249 patients receiving high-dose (1-3 gm/m(2)) cytarabine, using proportional hazards regression to adjust for differences in prognostic variables. One-year transplantation-related mortality was similar among the cohorts. Five-year relapse rates were 49% (95% confidence interval CI} = 39%-58%) with no consolidation, 35% (95% CI = 29%-42%) with standard-dose cytarabine, and 40% (95% CI = 33%-48%) with high-dose cytarabine (P = .07). Five-year leukemia-free survival rates were 39% (95% CI = 30%-47%) with no consolidation, 53% (95% CI = 46%-60%) with standard-dose cytarabine, and 48% (95% CI = 40%-56%) with high-dose cytarabine (P = .03). Similarly, 5-year overall survival was better in those patients receiving consolidation: 42% (95% CI = 34%-51%) with no consolidation, 59% (95% CI = 52%-65%) with standard-dose cytarabine, and 54% (95% CI = 46%-61%) with high-dose cytarabine (P = .01). Although most patients received 1 or 2 cycles of consolidation, the number of courses had no detectable effect on transplantation outcome. In multivariate analysis, risks of relapse and treatment failure were lower in the patients receiving consolidation, especially among those patients receiving blood cell grafts. Outcomes with standard-dose and high-dose cytarabine were similar. Based on our findings, we recommend that patients with AML in first remission receive consolidation before undergoing autotransplantation." @default.
• W2040066655 created "2016-06-24" @default.
• W2040066655 creator A5001124933 @default.
• W2040066655 creator A5009654984 @default.
• W2040066655 creator A5012400900 @default.
• W2040066655 creator A5014838335 @default.
• W2040066655 creator A5017044459 @default.
• W2040066655 creator A5019979915 @default.
• W2040066655 creator A5023700544 @default.
• W2040066655 creator A5025720984 @default.
• W2040066655 creator A5025894116 @default.
• W2040066655 creator A5031254185 @default.
• W2040066655 creator A5036224917 @default.
• W2040066655 creator A5037299848 @default.
• W2040066655 creator A5040300777 @default.
• W2040066655 creator A5041206856 @default.
• W2040066655 creator A5042450014 @default.
• W2040066655 creator A5042915360 @default.
• W2040066655 creator A5050723566 @default.
• W2040066655 creator A5051138260 @default.
• W2040066655 creator A5052924450 @default.
• W2040066655 creator A5059797628 @default.
• W2040066655 creator A5063350015 @default.
• W2040066655 creator A5063351800 @default.
• W2040066655 creator A5066741737 @default.
• W2040066655 creator A5068847117 @default.
• W2040066655 creator A5070132319 @default.
• W2040066655 creator A5071626502 @default.
• W2040066655 creator A5076550283 @default.
• W2040066655 creator A5076735212 @default.
• W2040066655 creator A5082092102 @default.
• W2040066655 creator A5085360755 @default.
• W2040066655 creator A5088486180 @default.
• W2040066655 creator A5089893290 @default.
• W2040066655 creator A5091433944 @default.
• W2040066655 date "2006-02-01" @default.
• W2040066655 modified "2023-10-18" @default.
• W2040066655 title "Pretransplantation Consolidation Chemotherapy Decreases Leukemia Relapse after Autologous Blood and Bone Marrow Transplants for Acute Myelogenous Leukemia in First Remission" @default.
• W2040066655 cites W1930980342 @default.
• W2040066655 cites W1973617793 @default.
• W2040066655 cites W2060143975 @default.
• W2040066655 cites W2060342748 @default.
• W2040066655 cites W2098854099 @default.
• W2040066655 cites W2147112815 @default.
• W2040066655 cites W2270683839 @default.
• W2040066655 cites W2312509177 @default.
• W2040066655 cites W2315969116 @default.
• W2040066655 cites W2323075627 @default.
• W2040066655 cites W2326956962 @default.
• W2040066655 cites W2327572111 @default.
• W2040066655 cites W2331024001 @default.
• W2040066655 cites W4247507468 @default.
• W2040066655 doi "https://doi.org/10.1016/j.bbmt.2005.10.013" @default.
• W2040066655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16443518" @default.
• W2040066655 hasPublicationYear "2006" @default.
• W2040066655 type Work @default.
• W2040066655 sameAs 2040066655 @default.
• W2040066655 citedByCount "21" @default.
• W2040066655 countsByYear W20400666552012 @default.
• W2040066655 countsByYear W20400666552013 @default.
• W2040066655 countsByYear W20400666552014 @default.
• W2040066655 countsByYear W20400666552015 @default.
• W2040066655 countsByYear W20400666552016 @default.
• W2040066655 countsByYear W20400666552018 @default.
• W2040066655 crossrefType "journal-article" @default.
• W2040066655 hasAuthorship W2040066655A5001124933 @default.
• W2040066655 hasAuthorship W2040066655A5009654984 @default.
• W2040066655 hasAuthorship W2040066655A5012400900 @default.
• W2040066655 hasAuthorship W2040066655A5014838335 @default.
• W2040066655 hasAuthorship W2040066655A5017044459 @default.
• W2040066655 hasAuthorship W2040066655A5019979915 @default.
• W2040066655 hasAuthorship W2040066655A5023700544 @default.
• W2040066655 hasAuthorship W2040066655A5025720984 @default.
• W2040066655 hasAuthorship W2040066655A5025894116 @default.
• W2040066655 hasAuthorship W2040066655A5031254185 @default.
• W2040066655 hasAuthorship W2040066655A5036224917 @default.
• W2040066655 hasAuthorship W2040066655A5037299848 @default.
• W2040066655 hasAuthorship W2040066655A5040300777 @default.
• W2040066655 hasAuthorship W2040066655A5041206856 @default.
• W2040066655 hasAuthorship W2040066655A5042450014 @default.
• W2040066655 hasAuthorship W2040066655A5042915360 @default.
• W2040066655 hasAuthorship W2040066655A5050723566 @default.
• W2040066655 hasAuthorship W2040066655A5051138260 @default.
• W2040066655 hasAuthorship W2040066655A5052924450 @default.
• W2040066655 hasAuthorship W2040066655A5059797628 @default.
• W2040066655 hasAuthorship W2040066655A5063350015 @default.
• W2040066655 hasAuthorship W2040066655A5063351800 @default.
• W2040066655 hasAuthorship W2040066655A5066741737 @default.
• W2040066655 hasAuthorship W2040066655A5068847117 @default.
• W2040066655 hasAuthorship W2040066655A5070132319 @default.
• W2040066655 hasAuthorship W2040066655A5071626502 @default.
• W2040066655 hasAuthorship W2040066655A5076550283 @default.
• W2040066655 hasAuthorship W2040066655A5076735212 @default.
• W2040066655 hasAuthorship W2040066655A5082092102 @default.
• W2040066655 hasAuthorship W2040066655A5085360755 @default.
• W2040066655 hasAuthorship W2040066655A5088486180 @default.
• W2040066655 hasAuthorship W2040066655A5089893290 @default.
• W2040066655 hasAuthorship W2040066655A5091433944 @default.

• next